Repurposing of Drugs–The Ketamine Story
Author:
Affiliation:
1. Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States
Funder
National Institute on Alcohol Abuse and Alcoholism
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01193
Reference137 articles.
1. Antidepressant based on party drug gets backing from FDA advisory group
2. US Food and Drug Administration press release FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression; Available Only at a Certified Doctor’s Office or Clinic, March 05, 2019. https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified.
3. Depression and Other Common Mental Disorders: Global Health Estimates; World Health Organization, 2017. WHO reference number: WHO/MSD/MER/2017.2.
4. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
5. Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Deciphering Ketamine’s Dual Outcomes: Distinguishing Psychotic from Antidepressant Effects, and Their Temporal Dynamics in Mice;2024-06-06
2. Design, Synthesis, and Activity Evaluation of Fluorine-Containing Scopolamine Analogues as Potential Antidepressants;Journal of Medicinal Chemistry;2024-02-14
3. Chirality of New Drug Approvals (2013–2022): Trends and Perspectives;Journal of Medicinal Chemistry;2024-02-12
4. Application of Ketamine in Pain Management and the Underlying Mechanism;Pain Research and Management;2023-08-16
5. Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder;Frontiers in Neuroscience;2023-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3